Form 4 for SGMT Sagimet Biosciences Inc.
Accepted 2023-07-20 00:00:00 ET · period of report 2023-07-18 · accession 0001104659-23-082729 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | C - Cnv Deriv | — | +4,117 | 12.8K | +47% | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | A - Grant | — | +8,677 | 8,677 | New | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | D - Sale to Iss | — | -8,677 | 0 | -100% | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | C - Cnv Deriv | $0.00 | -327.3K | 0 | -100% | $0 |
| DM | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | D - Sale to Iss | $0.00 | -52.6K | 0 | -100% | $0 |
| DM | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | A - Grant | $0.00 | +52.6K | 3,349 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2023-07-18 | C | A | 4,117 | — | 12,794 | D | — | — | (F2) Upon closing of the Issuer's initial public offering, each share of Series E Preferred Stock automatically converted on a 79.4784-to-one basis into shares of the Issuer's Series A Common Stock. The Series E Preferred Stock had no expiration date. |
| 2 | Common | Series A Common Stock | 2023-07-18 | A | A | 8,677 | — | 8,677 | D | — | — | (F1) Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock. |
| 3 | Common | Common Stock | 2023-07-18 | D | D | 8,677 | — | 0 | D | — | — | (F1) Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock. |
| 4 | Derivative | Series E Preferred Stock | 2023-07-18 | C | D | 327,309 | $0.00 | 0 | D | — · — to — | 4,117 Series A Common Stock | (F1) Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | D | D | 2,086 | $0.00 | 0 | D | $11.13 · — to 2024-03-12 | 2,086 Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | A | A | 23,839 | $0.00 | 23,839 | D | $6.36 · — to 2031-01-26 | 23,839 Series A Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | D | D | 23,839 | $0.00 | 0 | D | $6.36 · — to 2031-01-26 | 23,839 Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | A | A | 23,216 | $0.00 | 23,216 | D | $6.36 · — to 2029-04-27 | 23,216 Series A Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | D | D | 23,216 | $0.00 | 0 | D | $6.36 · — to 2029-04-27 | 23,216 Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | A | A | 144 | $0.00 | 144 | D | $23.05 · — to 2025-02-05 | 144 Series A Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 11 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | A | A | 2,086 | $0.00 | 2,086 | D | $11.13 · — to 2024-03-12 | 2,086 Series A Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 12 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | D | D | 3,349 | $0.00 | 0 | D | $23.05 · — to 2024-12-16 | 3,349 Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 13 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | A | A | 3,349 | $0.00 | 3,349 | D | $23.05 · — to 2024-12-16 | 3,349 Series A Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |
| 14 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | D | D | 144 | $0.00 | 0 | D | $23.05 · — to 2025-02-05 | 144 Common Stock | (F3) The shares underlying this option are fully vested and exercisable as of the date hereof. |